Doctors present first barrier for rare disease patients
Overcoming the doctor’s ego is a first hurdle for many rare disease patients in search of a diagnosis.
diagnosis and treatment
Why Europe’s health policies must prioritize chronic kidney disease
Undetected Chronic Kidney Disease affects millions in Europe, but it could be preventable, manageable and tackled with the right policies.
Rewriting Alzheimer’s future together – a call to action for G7 countries
Treatments for this disease have already advanced dramatically, but there is much further to go. We must take this historic opportunity to usher in a new era
BE PIONEERING: The benefits of unlocking the value of diagnostic innovation in Alzheimer’s [Promoted content]
There is an urgent need to improve access to new innovations in the diagnosis and treatment of Alzheimer’s disease. Embracing breakthroughs such as blood-based biomarker testing, has the potential to transform timely, accurate diagnosis for the benefit…
The Time is Now: Transforming Care in Lupus Together
An interview moderated by Robert Fogel, Vice President, Global Medical Affairs, Respiratory & Immunology, AstraZeneca, with Professor Marta Mosca and Patrick Wildman
Alzheimer’s Disease: detection, diagnosis, treatment [Advocacy Lab Content]
It is estimated that over 7 million people are living with Alzheimer’s Disease in Europe, and there is increasing concern about the ability to combat the disease with Europe’s ageing population. In this series of articles, Euractiv will exp…